Zhejiang Xianju Pharmaceutical Co.,Ltd.

002332

CNE100000K64

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
12.16 ^CNY	-0.82%		-1.94%	-4.78%

May. 30	Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024	CI
May. 22	Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2023	CI

Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2022

May 24, 2023 at 03:32 pm EDT

Zhejiang Xianju Pharmaceutical Co.,Ltd. announced that at its AGM held on May 23, 2023, shareholders approved cash dividend of CNY 3.00 per 10 shares (tax included) for the year 2022.

Latest news about Zhejiang Xianju Pharmaceutical Co.,Ltd.

Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 05 June 2024	May. 30	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2023	May. 21	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Year 2023	Apr. 24	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Xianju Pharma to Invest 33 Million Yuan in Local Drug R&D Firm	Dec. 27	MT
Hangzhou Yuhong Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 80 million in funding from Zhejiang Xianju Pharmaceutical Co.,Ltd., Jiaxing Miyin Yuhong Equity Investment Partnership Enterprise (L.P.), Hainan Huishengde Enterprise Management Partnership Enterprise (L.P.), Hangzhou Yulin Enterprise Management Partnership Enterprise (L.P.)	Dec. 25	CI
Zhejiang Xianju Pharmaceutical's Flumazenil Injection Chosen for China's Centralized Bid	Nov. 08	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023	23-05-29	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2022	23-05-24	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2022	23-04-26	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Zhejiang Xianju Pharma’s Abortion Tablet Passes Consistency Evaluation	23-03-10	MT
Zhejiang Xianju Pharma Logs 20.4% Jump in 2022 Profit	23-02-24	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Ningbo Linghan Enterprise Management Partnership Enterprise (Limited Partnership) entered into equity transaction contract to acquire 14.60% stake in Hangzhou Weisibo Medical Technology Co., Ltd. from Zhejiang Xianju Pharmaceutical Co.,Ltd. for CNY 8 million.	22-12-28	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves Management Elections	22-12-26	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component A Share Index	22-12-09	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd.(SZSE:002332) dropped from Shenzhen Stock Exchange Component Index	22-12-09	CI
Zhejiang Xianju Pharmaceutical Receives Regulatory Approval for Injection	22-11-02	MT
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 8, 2022	22-05-31	CI
Zhejiang Xianju Pharmaceutical Co.,Ltd. Approves 2021 Profit Distribution Plan	22-05-13	CI

Chart Zhejiang Xianju Pharmaceutical Co.,Ltd.

Duration

Period

Chart Zhejiang Xianju Pharmaceutical Co.,Ltd.

More charts

ZHEJIANG XIANJU PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the research, manufacture and distribution of steroid active pharmaceutical ingredients (APIs) and preparations. The Company's products are mainly categorized into cortex hormone drugs, gynecology and family planning drugs, as well as anesthesia drugs and muscle relaxants. The Company is also involved in the provision of respiratory drugs, immunomodulators, dermatology drugs, anaesthetic drugs and others. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Zhejiang Xianju Pharmaceutical Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

12.16 CNY

Average target price

15.21 CNY

Spread / Average Target

+25.08%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG XIANJU PHARMACEUTICAL CO.,LTD.	-4.78%	1.66B
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals